IN DEPTH How ambitious are the emissions targets of pharma and biotech companies? Should Covid-19 clinical trial plans still centre around EUAs? Manufacturing Continuous manufacturing builds on hype but adoption remains gradual Brexit, Covid-19, and a drive for sustainability has bumped the move towards continuous manufacturing, even though large-scale investment drags, writes Adam Zamecnik. R&D Can Relmada’s fast-acting pill for major depressive disorder compete in a crowded market? Cell Therapy Access to CAR-T therapies in Central and Eastern Europe in “catch-up” mode compared to the West How ambitious are the emissions targets of pharma and biotech companies? Should Covid-19 clinical trial plans still centre around EUAs? 06/01/2022 13:44:09
How ambitious are the emissions targets of pharma and biotech companies?
Should Covid-19 clinical trial plans still centre around EUAs?